Grouping patients according to their medication status (no medication vs anti-inflammatory/immunosuppressive medication) showed a trend to lower NOX4 levels in patients receiving therapeutic interventions ( Fig. 1 D).
← all excerpts
NADPH oxidase 4 is protective and not fibrogenic in intestinal inflammation.
1
—
—